Institutional members access full text with Ovid®

Share this article on:

Scedosporium Infections at a Cancer Center Over a 10-Year Period (2001–2010)

Rolfe, Nancy E. MD*; Sandin, Ramon L. MD; Greene, John N. MD

Infectious Diseases in Clinical Practice: March 2014 - Volume 22 - Issue 2 - p 71–74
doi: 10.1097/IPC.0b013e318297d5bf
Review Articles

Abstract: To determine if there has been an increase in Scedosporium infection at our cancer center, we compared the incidence to previously published data from our institution. A retrospective analysis of records of 12 patients with cancer with culture-proven Scedosporium infection from the last decade was performed. Types of malignancy included both hematologic disease, such as leukemia and lymphoma, and solid tumors, such as breast and lung cancer. Risk factors for Scedosporium infection include prolonged neutropenia, bronchiectasis, and immunosuppressive therapy. The mortality rate for patients with Scedosporium prolificans infection was 75%, whereas patients with Scedosporium apiospermum infection were more likely to die of their underlying malignancy than infection.

From the *Morsani College of Medicine, University of South Florida; and †Department of Hematopathology and Laboratory Medicine, and ‡Department of Infectious Diseases, H. Lee Moffitt Cancer Center, Tampa, FL.

Correspondence to: John N. Greene, MD, Department of Infectious Diseases, H. Lee Moffitt Cancer Center, 12902 Magnolia Drive, Tampa, FL 33612. E-mail: john.greene@moffitt.org.

The authors have no funding or conflicts of interest to disclose.

© 2014 by Lippincott Williams & Wilkins.